Atomwise Company

The Atomwise Advantage Using computers to discover medicines is a great idea, but execution is everything. With lives and budgets on the line, accuracy matters. Previous attempts haven't always met expectations. The techniques of the day were limited by the knowledge and computers available. Today, things are different. They have invented cutting-edge machine learning algorithms that are built specifically for the world's most powerful computers. They use one of the world's top supercomputers to analyze databases 1000 times larger than those used in the past. This lets us deliver what many others can't: precise and reliable medicinal predictions.
Technology: Clinical Applications
Industry: AI for Longevity
Headquarters: United States
Founded Date: 2012-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 18
Total Funding: $174.3M
Estimated Revenue: $10M to $50M
Last Funding Type: Series B

Visit Website
hello@atomwise.com
https://twitter.com/atomwiseinc
Register and Claim Ownership